PharmEasy

Equity

₹6/share

+₹21 (1.8%)

Indicative liquidity

Not Filed

Min. Investment

₹3,000

Lot Size

500 shares

52 Week low

₹5.59

52 Week high

₹8.5

Start investing

Ready to invest in PharmEasy?

Create your account to place buy orders, track settlements, and manage your watchlist.

Place buy & sell intents with RM support
Track settlement milestones in one place
Save listings to your watchlist

Indicative price

₹6 / share

Min. investment · ₹3,000

Already have an account? Log in

Get price alerts first

Loading chart…

About Company

PharmEasy is among the top on-demand digital healthcare and e-pharmacy platform in India backed by its technology-enabled ecosystem offering delivery of medicines, diagnostic testing, teleconsultation and services across the healthcare spectrum. API Holdings — the parent of PharmEasy, which was founded in 2015 and is based out of Mumbai — has become a key player in India’s health-tech space making medicines and services more accesible across urban and semi-urban markets.

Its platform allows customers to order prescription drugs, schedule laboratory tests, avail of health packages, consult doctors online, and buy wellness and healthcare products via its mobile application and website. PharmEasy supply-chain and partner-pharmacy has a deep presence in all major parts of India enabling large-scale delivery, both for last-mile medicines and diagnostics. Apart from that, the company expanded its market further through the acquisition of Thyrocare, one among India's largest diagnostic chains — bringing a strong complement of capabilities to deeper integration between diagnostics and digital healthcare delivery.

Founded

2015

CEO

Rahul Guha

Industry

Healthcare & Pharmaceuticals

Employees

N/A

Headquarters

Mumbai, Maharashtra

Website

N/A

ISIN

INE0DJ201029

CIN Number

U60100MH2019PLC323444

Depository Number

N/A

Depository

NSDL & CDSL

PAN Number

AASCA1201E

RTA

N/A

Total Shares

17,03,24,95,304

Risk Disclosure & Important Information

Investment in unlisted shares carries significant risks. Please read carefully:

Limited Liquidity: Unlisted shares are traded over-the-counter and may be difficult to sell quickly or at desired prices

Price Volatility: Prices can fluctuate significantly based on supply dynamics in the unlisted market

No Guaranteed IPO: There is no guarantee that NSE will complete its IPO in the expected timeline or at all

Regulatory Risks: Changes in regulations, pending approvals, or compliance issues may delay or affect IPO plans

Valuation Uncertainty: IPO pricing may differ from current unlisted market valuations

Lock-in Period: 6-month mandatory lock-in post-IPO restricts immediate sale after listing

This is not investment advice. Please do your own due diligence and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.